SBRI Healthcare is one of the support offered in the Innovation Exchange – it provides funds and targeted support for early stage companies and has a portfolio of over 150 companies developing solutions for healthcare needs.
In this session, Karen Livingstone, National Director of the Innovation Exchange and SBRI Healthcare will outline how you can register with your innovation exchange, secure the assistance of the AHSNs and potentially secure funding and resources through SBRI healthcare.
This presentation will give an overview of the growth of the use of 3D printing in the manufacture of medical devices, and the potential for bioprinting in the generation of combination products.
3D printing now has a 20 year track record of use in the manufacture of medical devices, and the presentation will review how applications have grown through application in teeth aligners, surgical guides, hearing aids and orthotics and prosthetics, and how the understanding and regulation of these products has matured over that time, and the outlook for future applications.
Bioprinting technologies are now emerging, and share much basic technology with 3D printing, and so working from the understanding gained from 3D printing’s history the presentation will explore how bioprinting could be used to enhance medical devices, generating combination products with enhanced functionality.
Four years ago, Device Access was granted a commercial licence from NHS Digital to access over 900+million pseudonymised patient health records. This data allows them to examine diagnosis, procedure and spend data, nationally and by each NHS Hospital in England, and in turn enables Device Access to see how their client’s technology could affect the current patient pathway, assist in building a value story with NICE and a solid business case for local and national NHS Hospital adoption.
Michael will explain why the NHS needs technology more than ever before, and how companies need to develop a market access strategy around removing adoption barriers by communicating the benefits to patients, providers of care, payers of care and being able to justify the sales price and maximising the availability of the technology to the right patients.
The medical device industry brings many innovative and iterative products to the healthcare market every year. How do the changing needs and demands of clinicians, patients, managers and policy-makers influence product design and how has this changed over the years? From the early days of the modern industry to some of the driving principles that impact development and design today.
What changes can we anticipate in the near future?
Increasingly the device industry has diversified into service provision. How do these services incorporate the perspective of the patient and bring greater efficiency?
How is demand stimulated and who is the real customer? Is industry responding in the right way or is there still a long way to go?
The behaviours and incentives in different health systems need to be considered in product and service development. At the same time the market is increasingly globalised. Can such diversity be incorporated at an affordable cost? How does the industry generate the data to demonstrate value & benefit – how is this designed in to evidence programmes?
Healthcare organisations and systems globally are facing unique pressures, many of which are strategic in nature. This session will outline the imperative for healthcare leaders to take an ecosystem approach in seeking to develop their strategy and in enabling new forms of value and innovation. Whilst health organisations currently are overly focused on activities within their own organisational boundaries, this talk will suggest that new forms of value and new types of services cannot be delivered in isolation. Rather they require strategic partnerships and new business models that are enhanced when taking an ecosystem approach.
The presentation will focus on three areas; namely, what is an ecosystem, how can new forms of value be developed in ecosystems, and how is leadership exercised across ecosystem
A great place to engage with innovators and stakeholders across the innovation landscape.
A well organised exhibition that generated plenty of foot fall. We would happily support Med-Tech Innovation Expo again, and look forward to the relocation to the NEC.
We met several companies who gave us interesting and knowledgeable information which will assist us in our future product and manufacturing decisions.
Great show for presenting our company to the medical device marketplace we had plenty of interesting conversations which am i sure will convert into business opportunities.